Fructose- 1,6-Bisphosphate Supports Cerebral Energy Metabolism in Pigs after Ischemic Brain Injury Caused by Experimental Particle Embolization
DOI:
https://doi.org/10.1532/HSF98.20061079Abstract
Background. Fructose-1,6-bisphosphate (FDP) is a high-energy intermediate that enhances glycolysis, preserves cellular adenosine triphosphate stores, and prevents the increase of intracellular calcium in ischemic tissue. Since it has been shown to provide metabolic support to the brain during ischemia, we planned this study to evaluate whether FDP is neuroprotective in the setting of combining hypothermic circulatory arrest (HCA) and irreversible embolic brain ischemic injury.
Methods. Twenty pigs were randomly assigned to receive 2 intravenous infusions of either FDP (500 mg/kg) or saline. The first infusion was given just before a 25-minute period of HCA and the second infusion immediately after HCA. Immediately before HCA, the descending aorta was clamped and 200 mg of albumin-coated polystyrene microspheres (250-750 mm in diameter) were injected into the isolated aortic arch in both study groups.
Results. There were no significant differences between the study groups in terms of neurological outcome. Brain lactate/pyruvate ratio was significantly lower (P = .015) and brain pyruvate levels (P = .013) were significantly higher in the FDP group compared with controls. Brain lactate levels were significantly higher 8 hours after HCA (P = .049).
Conclusion. The administration of FDP before and immediately after HCA combined with embolic brain ischemic injury was associated with significantly lower brain lactate/pyruvate ratio and significantly higher levels of brain pyruvate, as well as lower lactate levels 8 hours after HCA. FDP seems to protect the brain by supporting energy metabolism. The neurological outcome was not improved, most likely resulting from the irreversible nature of the microsphere occlusion.
References
Bickler PE, Buck LT. 1996. Effects of fructose-1,6-bisphosphate on glutamate release and ATP loss from rat brain slices during hypoxia. J Neurochem 67:1463-8.nBickler PE, Kelleher JA. 1992. Fructose-1,6-bisphosphate stabilizes brain intracellular calcium during hypoxia in rats. Stroke 23:1617-22.nCardenas A, Hurtado O, Leza JC, et al. 2000. Fructose-1,6-bisphosphate inhibits the expression of inducible nitric oxide synthase caused by oxygen-glucose deprivation through the inhibition of glutamate release in rat forebrain slices. Naunyn Schmiedebergs Arch Pharmacol 362:208-12.nDahlbacka S, Heikkinen J, Kaakinen T, et al. 2005. pH-stat versus alpha-stat acid-base management strategy during hypothermic circulatory arrest combined with embolic brain injury. Ann Thorac Surg 79:1316-25.nDuebener LF, Hagino I, Sakamoto T, et al. 2002. Effects of pH management during deep hypothermic bypass on cerebral microcirculation: alpha-stat versus pH-stat. Circulation 106:I103-8.nGobbel GT, Chan TY, Gregory GA, et al. 1994. Response of cerebral endothelial cells to hypoxia: modification by fructose-1,6-bisphosphate but not glutamate receptor antagonists. Brain Res 653:23-30.nHassinen IE, Nuutinen EM, Ito K, et al. 1991. Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism. Circulation 83:584-93.nHillered L, Persson L, Ponten U, et al. 1990. Neurometabolic monitoring of the ischaemic human brain using microdialysis. Acta Neurochir (Wien) 102:91-7.nJuvonen T, Weisz DJ, Wolfe D, et al. 1998. Can retrograde perfusion mitigate cerebral injury after particulate embolization? A study in a chronic porcine model. J Thorac Cardiovasc Surg 115:1142-59.nKaakinen T, Naukkarinen A, Tuominen H, et al. 2005. Neuronal ultra-structure is preserved by fructose-1,6-bisphosphate after hypothermic circulatory arrest in pigs. J Thorac Cardiovasc Surg 130:1475-6.nKawachi Y, Nakashima A, Toshima Y, et al. 2003. Stroke in thoracic aortic surgery: outcome and risk factors. Asian Cardiovasc Thorac Ann 11:52-7.nKelleher JA, Chan TY, Chan PH, et al. 1996. Protection of astrocytes by fructose 1,6-bisphosphate and citrate ameliorates neuronal injury under hypoxic conditions. Brain Res 726:167-73.nKuluz JW, Gregory GA, Han Y, et al. 1993. Fructose- 1,6-bisphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats. Stroke 24:1576-83.nLi LY, Wang HY, Shi JH. 1994. Protective effect of 1,6-diphosphate fructose in ischemic renal failure in elderly rats. Zhonghua Yi Xue Za Zhi 74:9-12,61.nMarkov AK, Causey AL, Didlake RH, et al. 2002. Prevention of alpha-naphthylthiourea-induced pulmonary edema with fructose-1,6-diphosphate. Exp Lung Res 28:285-99.nMcCullough JN, Zhang N, Reich DL, et al. 1999. Cerebral metabolic suppression during hypothermic circulatory arrest in humans. Ann Thorac Surg 67:1895-9.nPersson L, Hillered L. 1992. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J Neurosurg 76:72-80.nRomsi P, Kaakinen T, Kiviluoma K, et al. 2003. Fructose-1,6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs. J Thorac Cardiovasc Surg 125:686-98.nSawchuk A, Canal D, Slaughter M, et al. 1986. A comparison between fructose 1,6-diphosphate, glucose, or normal saline infusions and species-specific blood exchange transfusions in the treatment of bowel ischemia. Surgery 100:665-70.nSola A, Panes J, Xaus C, et al. 2003. Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine. J Leukoc Biol 73:74-81.nTavazzi B, Cerroni L, Di Pierro D, et al. 1990. Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate. Free Radic Res Commun 10:167-76.nTavazzi B, Starnes JW, Lazzarino G, et al. 1992. Exogenous fructose-1,6-bisphosphate is a metabolizable substrate for the isolated normoxic rat heart. Basic Res Cardiol 87:280-9.nTrimarchi GR, Arcadi FA, Imperatore C, et al. 1997. Effects of fructose-1,6-biphosphate on microsphere-induced cerebral ischemia in the rat. Life Sci 61:611-22.n
